Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice
- 1 September 2006
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 26 (17) , 6403-6411
- https://doi.org/10.1128/mcb.00755-06
Abstract
Members of the B7 family of cosignaling molecules regulate T-cell proliferation and effector functions by engaging cognate receptors on T cells. In vitro and in vivo blockade experiments indicated that B7-H4 (also known as B7S1 or B7x) inhibits proliferation, cytokine production, and cytotoxicity of T cells. B7-H4 binds to an unknown receptor(s) that is expressed on activated T cells. However, whether B7-H4 plays nonredundant immune regulatory roles in vivo has not been tested. We generated B7-H4-deficient mice to investigate the roles of B7-H4 during various immune reactions. Consistent with its inhibitory function in vitro, B7-H4-deficient mice mounted mildly augmented T-helper 1 (Th1) responses and displayed slightly lowered parasite burdens upon Leishmania major infection compared to the wild-type mice. However, the lack of B7-H4 did not affect hypersensitive inflammatory responses in the airway or skin that are induced by either Th1 or Th2 cells. Likewise, B7-H4-deficient mice developed normal cytotoxic T-lymphocyte reactions against viral infection. Thus, B7-H4 plays a negative regulatory role in vivo but the impact of B7-H4 deficiency is minimal. These results suggest that B7-H4 is one of multiple negative cosignaling molecules that collectively provide a fine-tuning mechanism for T-cell-mediated immune responses.Keywords
This publication has 48 references indexed in Scilit:
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaThe Journal of Experimental Medicine, 2006
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- B7‐H3 promotes acute and chronic allograft rejectionEuropean Journal of Immunology, 2005
- Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanismsFrontiers in Bioscience-Landmark, 2005
- SLAM Family Receptors Regulate Immunity with and without SAP-related AdaptorsThe Journal of Experimental Medicine, 2004
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- The B7–CD28 superfamilyNature Reviews Immunology, 2002
- Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient MiceScience, 2001
- Duration of TCR Stimulation Determines Costimulatory Requirement of T CellsImmunity, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995